Innovent Biologics, Inc.
Overview
Innovent Biologics, Inc. is a leading biopharmaceutical company headquartered in China, focused on the development, manufacturing, and commercialization of drugs for the treatment of cancer, autoimmune, metabolic, and other major diseases. The company is particularly recognized for its expertise in monoclonal antibody drugs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Innovent Biologics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Innovent Biologics (Suzhou) Co., Ltd.
China
Shanghai Junshi Biosciences Co., Ltd.
China
Wuxi Biologics (Cayman) Inc.
China
Altasciences Company Inc.
Canada
Boehringer Ingelheim BioXcellence GmbH
Germany
Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda
Brazil
C.H. Boehringer Sohn AG & Co. KG
Germany
Celerion, Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.